Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 73

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 9B
Chunk 73
---
. Wayne Holman, an individual, controls RCM. By reason of the provisions of Rule 13d-3 of the Securities Exchange Act of 1934, as amended, RCM and RCI may be deemed to own beneficially all of shares owned directly by RCILP. Each of RCM and RCI disclaim beneficial ownership of any of our company’s securities referenced above. The address for RCILP, RCI, RCM and Mr. Holman 348 W. 14th St., Fl. 4, New York, NY 10014.

(6)Consists of (i) 49,200 shares of Common Stock held by Mr. Schimmelpennink and (ii) 720,367 shares of Common Stock subject to options held by Mr. Schimmelpennink exercisable within 60 days of March 12, 2025.

(7)Consists of (i) 3,333 shares of Common Stock held by Mr. Olsson and (ii) 151,123 shares of Common Stock subject to options held by Mr. Olsson exercisable within 60 days of March 12, 2025.

(8)Consists of (i) 99,599 shares of Common Stock received by Dr. Odrich in the Merger as an equityholder of LENZ OpCo, and (ii) 60,713 shares of Common Stock subject to options held by Dr. Odrich exercisable within 60 days of March 12, 2025.

(9)Consists of shares of (i) 3,188 shares of Common Stock held by Mr. Chevallard and (ii) 54,166 shares of Common Stock subject to options held by Mr. Chevallard exercisable within 60 days of March 12, 2025.

(10)Consists of shares of Common Stock subject to options held by Dr. Guerard exercisable within 60 days of March 12, 2025.

(11)Consists of (i) 95,034 shares of Common Stock received by James McCollum in the Merger as an equityholder of LENZ OpCo, which have been transferred to the McCollum Living Trust (ii) 477,600 shares of Common Stock received by the McCollum Living Trust in the Merger as an equityholder of LENZ OpCo, (iii) 6,575 shares of Common Stock subject